特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

組織診断の世界市場:市場規模、シェア、動向分析

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology & Product (ISH, Digital Pathology and Workflow), By Application (Breast Cancer, Prostate Cancer), By End Use, By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 681328
出版日 ページ情報 英文 240 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
組織診断の世界市場:市場規模、シェア、動向分析 Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology & Product (ISH, Digital Pathology and Workflow), By Application (Breast Cancer, Prostate Cancer), By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月17日 ページ情報: 英文 240 Pages
概要

当レポートでは、世界の組織診断市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 調査手法

第3章 組織診断市場の変数、動向、範囲

  • 市場区分と範囲
  • 普及率と成長見通しマッピング
  • SWOT分析:要因別
  • ファイブフォース分析

第4章 組織診断市場:技術別

  • 技術別動向分析
  • 免疫組織化学
  • in situ ハイブリダイゼーション (ISH)
  • 一次・特殊染色法
  • デジタルパソロジー・ワークフロー
  • 解剖病理学

第5章 組織診断市場:用途別

  • 用途別動向分析
  • 乳がん
  • 非小細胞肺がん (NSCLC)
  • 前立腺がん
  • 胃がん
  • その他

第6章 組織診断市場:最終用途カテゴリー別

  • 最終用途カテゴリー別動向分析
  • 病院
  • 研究ラボ
  • 薬事関係団体
  • 開発業務受託機関 (CRO)

第7章 組織診断市場:地域別

  • 地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 戦略的枠組み
  • 市場参加者分類
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Siemens Healthineers
    • Danaher
    • bioMerieux SA
    • QIAGEN
    • Johnson & Johnson Services, Inc.
    • Becton Dickinson & Company (BD)
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies
    • GE Healthcare
    • BioGenex
    • Cell Signaling Technology, Inc.
    • Bio SB
    • DiaGenic
図表

List of Tables

  • TABLE 1 CPT codes for IHC (CBR201610)
  • TABLE 2 Comparative analysis of major ISH software
  • TABLE 3 CPT codes that can be applied to digital pathology
  • TABLE 4 Hospital categorization on the basis of size
  • TABLE 5 Hospital categorization on the basis of location
  • TABLE 6 Hospital categorization on the basis of funding body
  • TABLE 7 Major partnerships for oncology companion diagnostics, U.S., 2017
  • TABLE 8 North America tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 9 North America immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 10 North America immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 11 North America immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 12 North America in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 13 North America anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 14 North America anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 15 North America anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 16 North America digital pathology
  • market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 17 North America tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 18 North America tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 19 U.S. tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 20 U.S. immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 21 U.S. immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 22 U.S. immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 23 U.S. in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 24 U.S. anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 25 U.S. anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 26 U.S. anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 27 U.S. digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 28 U.S. tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 29 U.S. tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 30 Canada tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 31 Canada immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 32 Canada immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 33 Canada immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 34 Canada in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 35 Canada anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 36 Canada anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 37 Canada anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 38 Canada digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 39 Canada tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 40 Canada tissue diagnostics market estimates & forecasts, by enduse, 2016 - 2027 (USD Million)
  • TABLE 41 Europe tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 42 Europe immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 43 Europe immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 44 Europe immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 45 Europe in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 46 Europe anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 47 Europe anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 48 Europe anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 49 Europe digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 50 Europe tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 51 Europe tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 52 Germany tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 53 Germany immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 54 Germany immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 55 Germany immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 56 Germany in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 57 Germany anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 58 Germany anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 59 Germany anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 60 Germany digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 61 Germany tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 62 Germany tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 63 France tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 64 France immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 65 France immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 66 France immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 67 France in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 68 France anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 69 France anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 70 France anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 71 France digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 72 France tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 73 France tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 74 Spain tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 75 Spain immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 76 Spain immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 77 Spain immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 78 Spain in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 79 Spain anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 80 Spain anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 81 Spain anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 82 Spain digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 83 Spain tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 84 Spain tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 85 Asia Pacific tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 86 Asia Pacific immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 87 Asia Pacific immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 88 Asia Pacific immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 89 Asia Pacific in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 90 Asia Pacific anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 91 Asia Pacific anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 92 Asia Pacific anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 93 Asia Pacific digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 94 Asia Pacific tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 95 Asia Pacific tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 96 Japan tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 97 Japan immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 98 Japan immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 99 Japan immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 100 Japan in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 101 Japan anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 102 Japan anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 103 Japan anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 104 Japan digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 105 Japan tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 106 Japan tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 107 China tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 108 China immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 109 China immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 110 China immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 111 China in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 112 China anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 113 China anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 114 China anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 115 China digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 116 China tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 117 China tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 118 India tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 119 India immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 120 India immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 121 India immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 122 India in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 123 India anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 124 India anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 125 India anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 126 India digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 127 India tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 128 India tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 129 Latin America tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 130 Latin America immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 131 Latin America immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 132 Latin America immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 133 Latin America in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 134 Latin America anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 135 Latin America anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 136 Latin America anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 137 Latin America digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 138 Latin America tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 139 Latin America tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 140 Brazil tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 141 Brazil immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 142 Brazil immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 143 Brazil immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 144 Brazil in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 145 Brazil anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 146 Brazil anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 147 Brazil anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 148 Brazil digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 149 Brazil tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 150 Brazil tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 151 Mexico tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 152 Mexico immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 153 Mexico immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 154 Mexico immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 155 Mexico in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 156 Mexico anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 157 Mexico anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 158 Mexico anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 159 Mexico digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 160 Mexico tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 161 Mexico tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 162 MEA tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 163 MEA immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 164 MEA immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 165 MEA immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 166 MEA in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 167 MEA anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 168 MEA anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 169 MEA anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 170 MEA digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 171 MEA tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 172 MEA tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 173 South Africa tissue diagnostics market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 174 South Africa immunohistochemistry market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 175 South Africa immunohistochemistry consumables estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 176 South Africa immunohistochemistry instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 177 South Africa in situ hybridization market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 178 South Africa anatomic pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 179 South Africa anatomic pathology consumables market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 180 South Africa anatomic pathology instruments market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 181 South Africa digital pathology market estimates & forecasts, by product, 2016 - 2027 (USD Million)
  • TABLE 182 South Africa tissue diagnostics market estimates & forecasts, by application, 2016 - 2027 (USD Million)
  • TABLE 183 South Africa tissue diagnostics market estimates & forecasts, by end use, 2016 - 2027 (USD Million)
  • TABLE 184 List of key emerging companies

List of Figures

  • FIG. 1 Market segmentation & scope
  • FIG. 2 Market summary
  • FIG. 3 Market research process
  • FIG. 4 Data triangulation techniques
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value chain based sizing & forecasting
  • FIG. 8 QFD modelling for market share assessment
  • FIG. 9 Market formulation & validation
  • FIG. 10 Market trends & outlook
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Global cancer incidence, as of September 2018
  • FIG. 13 Approved New Molecular Entities (NMEs) in 2016
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for applications, 2019
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global tissue diagnostics market: Technology outlook key takeaways
  • FIG. 19 Global tissue diagnostics market: Technology movement analysis
  • FIG. 20 Global immunohistochemistry for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 21 Global immunohistochemistry instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 22 Global immunohistochemistry slide staining systems for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 23 Global immunohistochemistry tissue microarrays for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 24 Global immunohistochemistry tissue processing systems for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 25 Global immunohistochemistry slide scanners for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 26 Global immunohistochemistry other products for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 27 Global immunohistochemistry consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 28 Global immunohistochemistry reagents for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 29 Global immunohistochemistry antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 30 Global immunohistochemistry kits for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 31 Global in-situ hybridization for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 32 Global in-situ hybridization instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 33 Global in-situ hybridization consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 34 Global in-situ hybridization software for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 35 Global primary & special staining for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 36 Key drivers for digital pathology
  • FIG. 37 Global digital pathology & workflow for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 38 Global digital pathology & workflow whole slide imaging for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 39 Global digital pathology & workflow image analysis informatics for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 40 Global digital pathology & workflow information management system storage & communication for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 41 Global anatomic pathology for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 42 Global anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 43 Global anatomic pathology microtomes & cryostat for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 44 Global anatomic pathology tissue processors for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 45 Global anatomic pathology automatic strainers for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 46 Global other anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 47 Global anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 48 Global anatomic pathology reagents & antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 49 Global anatomic pathology kits & probes for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 50 Global other anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 51 Global tissue diagnostics market: Application outlook key takeaways
  • FIG. 52 Global tissue diagnostics market: Application movement analysis
  • FIG. 53 Global tissue-based breast cancer diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 54 Global tissue-based NSCLC diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 55 Global tissue-based prostate cancer diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 56 Global tissue-based gastric cancer diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 57 Global tissue-based other cancer diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 58 Global tissue diagnostics market: End-use category outlook key takeaways
  • FIG. 59 Global tissue diagnostics market: End-use category movement analysis
  • FIG. 60 Regional distribution of hospitals, by funding body (2018)
  • FIG. 61 Global hospital-based tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 62 Global research laboratories market, 2016 - 2027 (USD Million)
  • FIG. 63 Global pharmaceutical organizations market, 2016 - 2027 (USD Million)
  • FIG. 64 Clinical trials for cancer (including neoplasm and tumour)
  • FIG. 65 Global CROs-based tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 66 Tissue diagnostics regional market : Key takeaways
  • FIG. 67 Tissue diagnostics regional outlook, 2019 & 2027
  • FIG. 68 North America tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 69 U.S. tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 70 Canada tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 71 Europe tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 72 Germany tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 73 France tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 74 Spain tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 75 Asia Pacific tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 76 Japan tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 77 China tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 78 India tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 79 Latin America tissue diagnostics market, 2016-2027 (USD Million)
  • FIG. 80 Brazil tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 81 Mexico tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 82 Middle East & Africa tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 83 South Africa tissue diagnostics market, 2016 - 2027 (USD Million)
  • FIG. 84 Participant categorization
  • FIG. 86 Impact analysis by key companies
  • FIG. 87 Market position analysis for public companies
  • FIG. 88 Strategy framework
目次
Product Code: 978-1-68038-399-7

The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

Further key findings from the report suggest:

IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share

A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.

Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth

A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer

Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease

Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures

North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings

The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace

Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market

Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Overview
  • 1.2 Market Segmentation & Scope
  • 1.3 Competitive Insights

Chapter 2 Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased database:
    • 2.1.2 GVR's internal database
    • 2.1.3 Secondary sources:
    • 2.1.4 Primary research:
    • 2.1.5 Details of primary research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data analysis models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Commodity flow analysis (Model 1)
      • 2.4.1.1 Approach 1: Commodity flow approach
    • 2.4.2 Volume price analysis (Model 2)
      • 2.4.2.1 Approach 2: Volume price analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Primary Sources
  • 2.7 Objectives
    • 2.7.1 Objective 1
    • 2.7.2 Objective 2

Chapter 3 Tissue Diagnostics Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Worldwide increase in cancer prevalence
      • 3.1.1.2 Advancements in imaging techniques and increasing affordability of diagnostics
      • 3.1.1.3 Growth of personalized therapeutics and diagnostics
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 The high costs associated with R&D and clinical trials
      • 3.1.2.2 Presence of non-value based reimbursement policy
  • 3.2 Penetration & Growth Prospect Mapping For Applications, 2019
  • 3.3 Tissue Diagnostics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Tissue Diagnostics Market : Technology Timeline
  • 3.6 Major Deals & Strategic Alliances Analysis
    • 3.6.1 Merger & acquisition
    • 3.6.2 Collaboration & partnership
    • 3.6.3 Agreement

Chapter 4 Tissue Diagnostics Market: Technology & Product Estimates & Trend Analysis

  • 4.1 Global Tissue Diagnostics Market: Technology Movement Analysis
  • 4.2 Immunohistochemistry
    • 4.2.1 Global immunohistochemistry for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.2.2 Instruments
      • 4.2.2.1 Global immunohistochemistry instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.2.2 Slide staining systems
      • 4.2.2.2.1 Global immunohistochemistry slide staining systems for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.2.3 Tissue microarrays
      • 4.2.2.3.1 Global immunohistochemistry tissue microarrays for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.2.4 Tissue processing systems
      • 4.2.2.4.1 Global immunohistochemistry tissue processing systems for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.2.5 Slide scanners
      • 4.2.2.5.1 Global immunohistochemistry slide scanners for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.2.6 Other products
      • 4.2.2.6.1 Global immunohistochemistry other products for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.2.3 Consumables
      • 4.2.3.1 Global immunohistochemistry consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.3.2 Reagents
      • 4.2.3.2.1 Global immunohistochemistry reagents for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.3.3 Antibodies
      • 4.2.3.3.1 Global immunohistochemistry antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.2.3.4 Kits
      • 4.2.3.4.1 Global immunohistochemistry kits for tissue diagnostics market, 2016 - 2027 (USD Million)
  • 4.3 In-situ Hybridization
    • 4.3.1 Global in-situ hybridization for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.3.2 Instruments
      • 4.3.2.1 Global in-situ hybridization instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.3.3 Consumables
      • 4.3.3.1 Global in-situ hybridization consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.3.4 Software
      • 4.3.4.1 Global in-situ hybridization software for tissue diagnostics market, 2016 - 2027 (USD Million)
  • 4.4 Primary & Special Staining
    • 4.4.1 Global primary & special staining for tissue diagnostics market, 2016 - 2027 (USD Million)
  • 4.5 Digital Pathology & Workflow
    • 4.5.1 Global digital pathology & workflow for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.5.2 Whole slide imaging
      • 4.5.2.1 Global digital pathology & workflow whole slide imaging for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.5.3 Image analysis informatics
      • 4.5.3.1 Global digital pathology & workflow image analysis informatics for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.5.4 Information management system storage & communication
      • 4.5.4.1 Global digital pathology & workflow information management system storage & communication for tissue diagnostics market, 2016 - 2027 (USD Million)
  • 4.6 Anatomic Pathology
    • 4.6.1 Global anatomic pathology for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.6.2 Instruments
      • 4.6.2.1 Global anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.2.2 Microtomes & cryostat
      • 4.6.2.2.1 Global anatomic pathology microtomes & cryostat for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.2.3 Tissue processors
      • 4.6.2.3.1 Global anatomic pathology tissue processors for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.2.4 Automatic strainers
      • 4.6.2.4.1 Global anatomic pathology automatic strainers for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.2.5 Other products
      • 4.6.2.5.1 Global other anatomic pathology instruments for tissue diagnostics market, 2016 - 2027 (USD Million)
    • 4.6.3 Consumables
      • 4.6.3.1 Global anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.3.2 Reagents & antibodies
      • 4.6.3.2.1 Global anatomic pathology reagents & antibodies for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.3.3 Kits & probes
      • 4.6.3.3.1 Global anatomic pathology kits & probes for tissue diagnostics market, 2016 - 2027 (USD Million)
      • 4.6.3.4 Others
      • 4.6.3.4.1 Global other anatomic pathology consumables for tissue diagnostics market, 2016 - 2027 (USD Million)

Chapter 5 Tissue Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1 Global Tissue Diagnostics Market: Application Movement Analysis
  • 5.2 Breast Cancer
    • 5.2.1 Global tissue-based breast cancer diagnostics market, 2016 - 2027 (USD Million)
  • 5.3 Non-small Cell Lung Cancer (NSCLC)
    • 5.3.1 Global tissue-based NSCLC diagnostics market, 2016 - 2027 (USD Million)
  • 5.4 Prostate Cancer
    • 5.4.1 Global tissue-based prostate cancer diagnostics market, 2016 - 2027 (USD Million)
  • 5.5 Gastric Cancer
    • 5.5.1 Global tissue-based gastric cancer diagnostics market, 2016 - 2027 (USD Million)
  • 5.6 Other Cancers
    • 5.6.1 Global tissue-based other cancer diagnostics market, 2016 - 2027 (USD Million)

Chapter 6 Tissue Diagnostics Market: End-use Category Estimates & Trend Analysis

  • 6.1 Global Tissue Diagnostics Market: End-use Category Movement Analysis
  • 6.2 Hospitals
    • 6.2.1 Global hospital-based tissue diagnostics market, 2016 - 2027 (USD Million)
  • 6.3 Research Laboratories
    • 6.3.1 Global research laboratories market, 2016 - 2027 (USD Million)
  • 6.4 Pharmaceutical Organizations
    • 6.4.1 Global pharmaceutical organizations market, 2016 - 2027 (USD Million)
  • 6.5 Contract Research Organizations (CROS)
    • 6.5.1 Global CROs-based tissue diagnostics market, 2016 - 2027 (USD Million)

Chapter 7 Tissue Diagnostics Market: Regional Estimates & Trend Analysis, by, Technology & Product, Application, & End-use

  • 7.1 Tissue Diagnostics Market Share By Region, 2019 & 2027
  • 7.2 North America
    • 7.2.1 North America tissue diagnostics market, 2016 - 2027 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.2.2.2 U.S. tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.2.2.3 U.S. tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.2.3.2 Canada tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.2.3.3 Canada tissue diagnostics market, by enduse, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe tissue diagnostics market, 2016 - 2027 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.3.2.2 Germany tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.3.2.3 Germany tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.3.3 France
      • 7.3.3.1 France tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.3.3.2 France tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.3.3.3 France tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.3.4 Spain
      • 7.3.4.1 Spain tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.3.4.2 Spain tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.3.4.3 Spain tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific tissue diagnostics market, 2016 - 2027 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.4.2.2 Japan tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.4.2.3 Japan tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.4.3.2 China tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.4.3.3 China tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.4.4.2 India tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.4.4.3 India tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America tissue diagnostics market, 2016-2027 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.5.2.2 Brazil tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.5.2.3 Brazil tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.5.3.2 Mexico tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.5.3.3 Mexico tissue diagnostics market, by end use, 2016 - 2027 (USD Million)
  • 7.6 Middle East & Africa (MEA)
    • 7.6.1 Middle East & Africa tissue diagnostics market, 2016 - 2027 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa tissue diagnostics market, by technology, 2016 - 2027 (USD Million)
      • 7.6.2.2 South Africa tissue diagnostics market, by application, 2016 - 2027 (USD Million)
      • 7.6.2.3 South Africa tissue diagnostics market, by end use, 2016 - 2027 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Categorization
  • 8.2 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.3 Public Companies
    • 8.3.1 Company market position analysis
  • 8.4 Private Companies
    • 8.4.1 List of key emerging companies
  • 8.5 Strategy Framework
  • 8.6 Company Profiles
    • 8.6.1 F. Hoffmann-La Roche Ltd.
      • 8.6.1.1 Company overview
      • 8.6.1.2 Financial performance
      • 8.6.1.3 Product benchmarking
      • 8.6.1.4 Strategic Initiatives
    • 8.6.2 Abbott Laboratories
      • 8.6.2.1 Company overview
      • 8.6.2.1.1 Alere, Inc.
      • 8.6.2.2 Financial performance
      • 8.6.2.3 Product benchmarking
      • 8.6.2.4 Strategic initiatives
    • 8.6.3 Siemens
      • 8.6.3.1 Company overview
      • 8.6.3.2 Financial performance
      • 8.6.3.3 Product benchmarking
      • 8.6.3.4 Strategic initiatives
    • 8.6.4 Danaher
      • 8.6.4.1 Company overview
      • 8.6.4.1.1 Beckman Coulter, Inc.
      • 8.6.4.2 Financial performance
      • 8.6.4.3 Product benchmarking
      • 8.6.4.4 Strategic initiatives
    • 8.6.5 bioMerieux SA
      • 8.6.5.1 Company overview
      • 8.6.5.2 Financial performance
      • 8.6.5.3 Product benchmarking
      • 8.6.5.4 Strategic initiatives
    • 8.6.6 QIAGEN
      • 8.6.6.1 Company overview
      • 8.6.6.2 Financial performance
      • 8.6.6.3 Product benchmarking
      • 8.6.6.4 Strategic initiatives
    • 8.6.7 Becton Dickinson & Company
      • 8.6.7.1 Company overview
      • 8.6.7.2 Financial performance
      • 8.6.7.3 Product benchmarking
      • 8.6.7.4 Strategic initiatives
    • 8.6.8 Merck KGaA
      • 8.6.8.1 Company overview
      • 8.6.8.1.1 Bio Reliance
      • 8.6.8.1.2 Sigma-Aldrich Co. LLC
      • 8.6.8.2 Financial performance
      • 8.6.8.3 Product benchmarking
      • 8.6.8.4 Strategic initiatives
    • 8.6.9 Thermo Fisher Scientific, Inc.
      • 8.6.9.1 Company overview
      • 8.6.9.1.1 Life Technologies Corporation
      • 8.6.9.1.2 Affymetrix, Inc.
      • 8.6.9.2 Financial performance
      • 8.6.9.3 Product benchmarking
    • 8.6.10 Agilent Technologies, Inc.
      • 8.6.10.1 Company overview
      • 8.6.10.2 Financial performance
      • 8.6.10.3 Product benchmarking
      • 8.6.10.4 Strategic initiatives
    • 8.6.11 GE Healthcare
      • 8.6.11.1 Company overview
      • 8.6.11.2 Financial performance
      • 8.6.11.3 Product benchmarking
      • 8.6.11.4 Strategic initiatives
    • 8.6.12 BioGenex
      • 8.6.12.1 Company overview
      • 8.6.12.2 Financial performance
      • 8.6.12.3 Product benchmarking
      • 8.6.12.4 Strategic initiatives
    • 8.6.13 Cell Signaling Technology, Inc.
      • 8.6.13.1 Company overview
      • 8.6.13.2 Financial performance
      • 8.6.13.3 Product benchmarking
      • 8.6.13.4 Strategic initiatives
    • 8.6.14 Bio SB
      • 8.6.14.1 Company overview
      • 8.6.14.2 Financial performance
      • 8.6.14.3 Product benchmarking
      • 8.6.14.4 Strategic initiatives
    • 8.6.15 DiaGenic ASA
      • 8.6.15.1 Company overview
      • 8.6.15.2 Financial performance
      • 8.6.15.3 Product benchmarking
      • 8.6.15.4 Strategic initiatives
    • 8.6.16 Sakura Finetek Japan Co. Ltd.
      • 8.6.16.1 Company overview
      • 8.6.16.2 Financial performance
      • 8.6.16.3 Product benchmarking
      • 8.6.16.4 Strategic initiatives
    • 8.6.17 Abcam plc
      • 8.6.17.1 Company overview
      • 8.6.17.2 Financial performance
      • 8.6.17.3 Product benchmarking
      • 8.6.17.4 Strategic initiatives
    • 8.6.18 Enzo Life Sciences, Inc.
      • 8.6.18.1 Company overview
      • 8.6.18.2 Financial performance
      • 8.6.18.3 Product benchmarking
      • 8.6.18.4 Strategic initiatives
    • 8.6.19 Master Diagnostica
      • 8.6.19.1 Company overview
      • 8.6.19.2 Financial performance
      • 8.6.19.3 Product benchmarking
      • 8.6.19.4 Strategic initiatives
    • 8.6.20 TissueGnostics GmbH
      • 8.6.20.1 Company overview
      • 8.6.20.2 Financial performance
      • 8.6.20.3 Product benchmarking
      • 8.6.20.4 Strategic initiatives